FORM 10-K/A

                        SECURITIES AND EXCHANGE COMMISSION
                                           Washington, D.C. 20549 

    	(Mark One)	ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF 
	              X 	THE SECURITIES EXCHANGE ACT OF 1934 

                                     For the fiscal year ended May 31, 1998

                                                               OR

       	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF 
                   THE SECURITIES EXCHANGE ACT OF 1934

                     For the transition period from                  to 
 
                                  Commission file number 0-14820

                                IMMUCOR, INC.
        (Exact name of registrant as specified in its charter)

      	Georgia 	                                 22-2408354
 (State or other jurisdiction of      (I.R.S. Employer Identification No.)
 incorporation or organization)

	3130 GATEWAY DRIVE,                              	30091
	P.O. BOX 5625                                  	(Zip Code)
	Norcross, Georgia
	(Address of principal executive offices)

  Registrant's telephone number, including area code, is (770) 441-2051

        Securities registered pursuant to Section 12(b) of the Act: 

                                 NONE

        Securities registered pursuant to Section 12(g) of the Act: 

                     COMMON STOCK, $.10 PAR VALUE
                           (Title of Class)

                     COMMON STOCK PURCHASE RIGHTS
                           (Title of Class)

	Indicate by check mark whether the registrant (1) has filed all reports
 required to be filed by Section 13 or 15(d) of the Securities Exchange Act
 of 1934 during the preceding 12 months (or for such shorter period that the
 Registrant was required to file such reports), and (2) has been subject to
 such filing requirements for the past 90 days.
                             YES 	X		NO 		
	Indicate by a check mark if disclosure of delinquent filers pursuant to Item
 405 of Regulation S-K is not contained herein, and will not be contained, to
 the best of registrant's knowledge, in definitive proxy or information
 statements incorporated by reference in Part III of this Form 10-K or any
 amendment to this Form 10-K.	[    X   ]

	As of July 31, 1998, the aggregate market value of the voting stock held by
 non-affiliates of the registrant was $74,545,537.  

	As of July 31, 1998,  there were 8,075,349 shares of common stock
 outstanding.


PART IV

Item 14.-Exhibits, Financial Statement Schedules, and Reports on Form 8-K.

(a)	Documents filed as part of this report: 

1.	Consolidated Financial Statements 

The Consolidated Financial Statements, Notes thereto, and Report of 
Independent Auditors thereon are included in Part II, Item 8 of this report. 

2.	Consolidated Financial Statement Schedule included in Part II, Item 8 of
this report 

Schedule II - Valuation and Qualifying Accounts 

	Other financial statement schedules are omitted as they are not required or
 not applicable.

3.	Exhibits 

3.1	Articles of Incorporation (composite as of December 22, 1989)
 (incorporated by reference to Exhibit 3.1 to Immucor, Inc.'s Quarterly
 Report on Form 10-Q for the fiscal quarter ended November 30, 1989). 

3.2	Bylaws (amended and restated as of August 28, 1991) (incorporated by
 reference to Exhibit 19 to Immucor, Inc.'s Quarterly Report on Form 10-Q for
 the fiscal quarter ended August 31, 1991).

4.1	Immucor, Inc. Shareholder Rights Plan, adopted April 7, 1989
 (incorporated by reference to Exhibit 4.1 to Immucor, Inc.'s Current Report
 on Form 8-K dated April 7, 1989). 

10.1	Standard Industrial Lease, dated July 21, 1982, between the Company and
 Colony Center, Ltd. (incorporated by reference to Exhibit 10.2 to Immucor,
 Inc.'s Annual Report on Form 10-K for the fiscal year ended May 31, 1985). 

10.1-1	Lease Amendment dated June 28, 1989, between the Company and Colony
 Center, Ltd. (incorporated by reference to Exhibit 10.1-1 to Immucor's
 Annual Report on Form 10-K for the fiscal year ended May 31, 1989). 

10.1-2	Lease Amendment dated November 8, 1991, between the Company and Colony
 Center, Ltd. (incorporated by reference to Exhibit 10.1-1 to Immucor's
 Annual Report on Form 10-K for the fiscal year ended May 31, 1992). 

10.1-3	Lease Agreement, dated February 2, 1996, between the Company and
 Connecticut General Life Insurance Company. (incorporated by reference to
 Exhibit 10.1-3 to Immucor's Annual Report on Form 10-K for the fiscal year
 ended May 31, 1996). 

10.1-4	Lease Amendment, dated March 8, 1998, between the Company and
 Connecticut General Life Insurance Company (incorporated by reference to
 Exhibit 10.1-4 to Immucor, Inc. Annual Report on Form 10-K for the fiscal
 year ended May 31, 1998). 

10.2	Agreement, dated March 11, 1983, between the Company and The Kansas City
 Group, as amended through January 21, 1985 (incorporated by reference to
 Exhibit 10.2 to Registration Statement No. 33-16275 on Form S-1). 

10.3	Agreement dated August 27, 1987, between the Company and the Kansas City
 Group amending Exhibit 10.2 (incorporated by reference to Exhibit 10.3 to
 Immucor's Annual Report on Form 10-K for the fiscal year ended May 31, 1989). 

10.4	United States Department of Health and Human Services Establishment
 License dated December 28, 1982, for the manufacture of biological products
 (incorporated by reference to Exhibit 10.12 to Registration Statement No.
 33-966 on Form S-1). 

10.5	United States Department of Health and Human Services Product License
 dated December 28, 1982, for the manufacture and sale of reagent red blood
 cells (incorporated by reference to Exhibit 10.13 to Registration Statement
 No. 33-966 on Form S-1). 

10.6	United States Department of Health and Human Services Product License
 dated May 20, 1983, for the manufacture and sale of blood grouping sera
 (incorporated by reference to Exhibit 10.14 to Registration Statement No.
 33-966 on Form S-1). 

10.7	United States Department of Health and Human Services Product License
 date November 18, 1983, for the manufacture and sale of anti-human serum
 (incorporated by reference to Exhibit 10.15 to Registration Statement No.
 33-966 on Form S-1). 

10.8*	Employment Agreement, dated January 1, 1986, between the Company and
 Edward L. Gallup (incorporated by reference to Exhibit 10.15 to Immucor,
 Inc. Annual Report on Form 10-K for the fiscal year ended May 31, 1986). 

10.8-1*	Amendment to Employment Agreement dated April 7, 1989, between the
 Company and Edward L. Gallup (incorporated by reference to Exhibit 10.12-1
 to Immucor's Annual Report on Form 10-K for the fiscal year ended
 May 31, 1989). 

10.9*	Employment Agreement, dated January 1, 1986, between the Company and
 Ralph A. Eatz (incorporated by reference to Exhibit 10.16 to Immucor, Inc.
 Annual Report on Form 10-K for the fiscal year ended May 31, 1986). 

10.9-1*	Amendment to Employment Agreement dated April 7, 1989, between the
 Company and Ralph A. Eatz (incorporated by reference to Exhibit 10.13-1 to
 Immucor's Annual Report on Form 10-K for the fiscal year ended May 31, 1989). 

10.10*	Employment Agreement, dated January 1, 1986, between the Company and
 Richard J. Still (incorporated by reference to Exhibit 10.17 to Immucor,
 Inc. Annual Report on Form 10-K for the fiscal year ended May 31, 1986). 

10.10-1*	Amendment to Employment Agreement dated April 7, 1989, between the
 Company and Richard J. Still (incorporated by reference to Exhibit 10.14-1
 to Immucor's Annual Report on Form 10-K for the fiscal year ended
 May 31, 1989). 

10.11*	Employment Agreement dated September 12, 1990, between Immucor GmbH
 and Josef Wilms (incorporated by reference to Exhibit 10.11 to Immucor, Inc.
 Annual Report on Form 10-K for the fiscal year ended May 31, 1991).

10.12*	Agreement dated December 31, 1993, between Immucor Italia, S.r.l. and
 Dr. Gioacchino De Chirico (incorporated by reference to Exhibit 10.12 to
 Immucor, Inc. Annual Report on Form 10-K for the fiscal year ended
 May 31, 1995).

10.13*	Agreement dated December 31, 1993, between Immucor Italia, S.r.l. and
 Dr. Gioacchino De Chirico (incorporated by reference to Exhibit 10.13 to
 Immucor, Inc. Annual Report on Form 10-K for the fiscal year ended
 May 31, 1995).

10.14*	1995 Stock Option Plan, including form of Stock Option Agreement used
 thereunder (incorporated by reference to Exhibit 10.14 to Immucor, Inc.
 Annual Report on Form 10-K for the fiscal year ended May 31, 1995).

10.15*	1990 Stock Option Plan, including form of Stock Option Agreement used
 thereunder (incorporated by reference to Exhibit 10.15 to Immucor, Inc.
 Annual Report on Form 10-K for the fiscal year ended May 31, 1995).

10.16*	Description of 1983 and 1984 Salary Reduction Plans (incorporated by
 reference to Exhibit 10.9 to Immucor, Inc.'s Annual Report on Form 10-K for
 the fiscal year ending	May 31, 1985).

10.17*	Description of 1983 Stock Option Plan (incorporated by reference to
 Exhibit 10.10 to Immucor, Inc.'s Annual Report on Form 10-K for the fiscal
 year ending May 31, 1985).

10.18*	1986 Incentive Stock Option Plan, amended July 29, 1987, including
 form of Stock Option Agreement used thereunder (incorporated by reference
 to Exhibit 10.9 to Registration Statement No. 33-16275 on Form S-1).

10.19*	Agreement dated April 7, 1998, between the Company and
 Steven C. Ramsey (incorporated by reference to Exhibit 10.19 to Immucor
 Inc's Annual Report on Form 10-K for the fiscal year ending May 31, 1998).

10.20*	Agreement dated July 26, 1997 between the Company and Josef Wilms
 (incorporated by reference to Exhibit 10.20 to Immucor Inc's Annual Report
 on Form 10-K for the fiscal year ending May 31, 1998).

21	Subsidiaries of the Registrant (incorporated by reference to Exhibit 21
 to Immucor Inc's Annual Report on Form 10-K for the fiscal year ending
 May 31, 1998).

23.1	Consent of Ernst & Young LLP (incorporated by reference to Exhibit
 23.1 to Immucor Inc's Annual Report on Form 10-K for the fiscal year ending
 May 31, 1998).

27	Financial Data Schedule (incorporated by reference to Exhibit 27 to
 Immucor Inc's Annual Report on Form 10-K for the fiscal year ending
 May 31, 1998).

27.1	Restated Financial Data Schedule for the fiscal years ended
 May 31, 1997 and 1996.
	
    *Denotes a management contract or compensatory plan or arrangement.


(b)  Reports on Form 8-K 

The Company did not file a Current Report on Form 8-K during the quarter
 ended May 31, 1998.

(c)	Exhibits

	The exhibits required to be filed with this Annual Report on Form 10-K
 pursuant to Item 601, of Regulation S-K are listed under "Exhibits" in
 Part IV, Item 14(a)(3) of this Annual Report on Form 10-K, and are 
 incorporated herein by reference.

(d)	Financial Statement Schedule
	
	The Financial Statement Schedule required to be filed with this Annual
 Report on Form 10-K is listed under "Financial Statement Schedule" in
 Part IV, Item 14(a)(2) of this Annual Report on Form 10-K, and is 
 incorporated herein by reference.

SIGNATURES

	Pursuant to the requirements of Section 13 or 15(d) of the Securities
 Exchange Act of 1934, the registrant has duly caused this amendment to the
 Form 10-K to be signed on its behalf by the undersigned, thereunto duly
 authorized.

IMMUCOR, INC.

By:	/s/ EDWARD L. GALLUP	
	Edward L. Gallup, Chairman of the Board of Directors,
	President and Chief Executive Officer
	August 20, 1998

 Pursuant to the requirements of the Securities Exchange Act of 1934, this
 amendment to the Form 10-K has been signed below by the following persons
 on behalf of the registrant and in the capacities and on the dates indicated. 

/s/ EDWARD L. GALLUP	
Edward L. Gallup, Director, Chairman of the Board of Directors,
President and Chief Executive Officer 
(Principal Executive Officer)
August 20, 1998

/s/ STEVEN C. RAMSEY	
Steven C. Ramsey, Vice President - Chief Financial Officer and Secretary
(Principal Financial and Accounting Officer)
August 20, 1998

/s/RALPH A. EATZ	
Ralph A. Eatz, Director, Senior Vice President - Operations 
August 20, 1998

/s/DANIEL T. MCKEITHAN	
Daniel T. McKeithan, Director
August 20, 1998

/s/G. BRUCE PAPESH	
G. Bruce Papesh, Director
August 20, 1998
	
Didier L. Lanson, Director 
August 20, 1998
	
Dr. Gioacchino De Chirico, Director, Director of European Operations and
President of Immucor Italia S.r.l. 
August 20, 1998
	
Dennis M. Smith, Jr., MD, Director
August 20, 1998

/s/JOSEPH E. ROSEN	
Joseph E. Rosen, Director
August 20, 1998

EXHIBIT INDEX

		
Number	Description	

3.1	Articles of Incorporation (composite as of December 22, 1989)
 (incorporated by reference to Exhibit 3.1 to Immucor, Inc.'s Quarterly
 Report on Form 10-Q for the fiscal quarter ended November 30, 1989). 

3.2	Bylaws (amended and restated as of August 28, 1991) (incorporated by
 reference to Exhibit 19 to Immucor, Inc.'s Quarterly Report on Form 10-Q for
 the fiscal quarter ended August 31, 1991).

4.1	Immucor, Inc. Shareholder Rights Plan, adopted April 7, 1989
 (incorporated by reference to Exhibit 4.1 to Immucor, Inc.'s Current Report
 on Form 8-K dated April 7, 1989). 

10.1	Standard Industrial Lease, dated July 21, 1982, between the Company and
 Colony Center, Ltd. (incorporated by reference to Exhibit 10.2 to Immucor,
 Inc.'s Annual Report on Form 10-K for the fiscal year ended May 31, 1985). 

10.1-1	Lease Amendment dated June 28, 1989, between the Company and Colony
 Center, Ltd. (incorporated by reference to Exhibit 10.1-1 to Immucor's
 Annual Report on Form 10-K for the fiscal year ended May 31, 1989). 

10.1-2	Lease Amendment dated November 8, 1991, between the Company and Colony 
 Center, Ltd. (incorporated by reference to Exhibit 10.1-1 to Immucor's Annual
 Report on Form 10-K for the fiscal year ended May 31, 1992). 

10.1-3	Lease Agreement, dated February 2, 1996, between the Company and
 Connecticut General Life Insurance Company. (incorporated by reference to
 Exhibit 10.1-3 to Immucor's Annual Report on Form 10-K for the fiscal year
 ended May 31, 1996). 

10.1-4	Lease Amendment, dated March 8, 1998, between the Company and
 Connecticut General Life Insurance Company (incorporated by reference to
 Exhibit 10.1-4 to Immucor's Annual Report on Form 10-K for the fiscal year
 ended May 31, 1998). 

10.2	Agreement, dated March 11, 1983, between the Company and The Kansas City 
 Group, as amended through January 21, 1985 (incorporated by reference to
 Exhibit 10.2 to Registration Statement No. 33-16275 on Form S-1). 

10.3	Agreement dated August 27, 1987, between the Company and the Kansas City
 Group amending Exhibit 10.2 (incorporated by reference to Exhibit 10.3 to
 Immucor's Annual Report on Form 10-K for the fiscal year ended May 31, 1989). 

10.4	United States Department of Health and Human Services Establishment
 License dated December 28, 1982, for the manufacture of biological products
 (incorporated by reference to Exhibit 10.12 to Registration Statement No.
 33-966 on Form S-1). 

10.5	United States Department of Health and Human Services Product License
 dated December 28, 1982, for the manufacture and sale of reagent red blood
 cells (incorporated by reference to Exhibit 10.13 to Registration Statement
 No. 33-966 on Form S-1). 

10.6	United States Department of Health and Human Services Product License
 dated May 20, 1983, for the manufacture and sale of blood grouping sera
 (incorporated by reference to Exhibit 10.14 to Registration Statement No.
 33-966 on Form S-1). 

10.7	United States Department of Health and Human Services Product License
 date November 18, 1983, for the manufacture and sale of anti-human serum
 (incorporated by reference to Exhibit 10.15 to Registration Statement No.
 33-966 on Form S-1). 

10.8*	Employment Agreement, dated January 1, 1986, between the Company and
 Edward L. Gallup (incorporated by reference to Exhibit 10.15 to Immucor,
 Inc. Annual Report on Form 10-K for the fiscal year ended May 31, 1986). 

10.8-1*	Amendment to Employment Agreement dated April 7, 1989, between the
 Company and Edward L. Gallup (incorporated by reference to Exhibit 10.12-1
 to Immucor's Annual Report on Form 10-K for the fiscal year ended
 May 31, 1989). 

10.9*	Employment Agreement, dated January 1, 1986, between the Company and
 Ralph A. Eatz (incorporated by reference to Exhibit 10.16 to Immucor, Inc.
 Annual Report on Form 10-K for the fiscal year ended May 31, 1986). 

10.9-1*	Amendment to Employment Agreement dated April 7, 1989, between the
 Company and Ralph A. Eatz (incorporated by reference to Exhibit 10.13-1 to
 Immucor's Annual Report on Form 10-K for the fiscal year ended May 31, 1989). 

10.10*	Employment Agreement, dated January 1, 1986, between the Company and
 Richard J. Still (incorporated by reference to Exhibit 10.17 to Immucor,
 Inc. Annual Report on Form 10-K for the fiscal year ended May 31, 1986). 

10.10-1*	Amendment to Employment Agreement dated April 7, 1989, between the
 Company and Richard J. Still (incorporated by reference to Exhibit 10.14-1
 to Immucor's Annual Report on Form 10-K for the fiscal year ended
 May 31, 1989). 

10.11*	Employment Agreement dated September 12, 1990, between Immucor GmbH
 and Josef Wilms (incorporated by reference to Exhibit 10.11 to Immucor, Inc.
 Annual Report on Form 10-K for the fiscal year ended May 31, 1991).

10.12*	Agreement dated December 31, 1993, between Immucor Italia, S.r.l. and
 Dr. Gioacchino De Chirico (incorporated by reference to Exhibit 10.12 to
 Immucor, Inc. Annual Report on Form 10-K for the fiscal year ended May 31,
 1995).

10.13*	Agreement dated December 31, 1993, between Immucor Italia, S.r.l. and
 Dr. Gioacchino De Chirico (incorporated by reference to Exhibit 10.13 to
 Immucor, Inc. Annual Report on Form 10-K for the fiscal year ended May 31,
 1995).

10.14*	1995 Stock Option Plan, including form of Stock Option Agreement used
 thereunder (incorporated by reference to Exhibit 10.14 to Immucor, Inc.
 Annual Report on Form 10-K for the fiscal year ended May 31, 1995).

10.15*	1990 Stock Option Plan, including form of Stock Option Agreement used
 thereunder (incorporated by reference to Exhibit 10.15 to Immucor, Inc.
 Annual Report on Form 10-K for the fiscal year ended May 31, 1995).

10.16*	Description of 1983 and 1984 Salary Reduction Plans (incorporated by
 reference to Exhibit 10.9 to Immucor, Inc.'s Annual Report on Form 10-K for
 the fiscal year ending May 31, 1985).

10.17*	Description of 1983 Stock Option Plan (incorporated by reference to
 Exhibit 10.10 to Immucor, Inc.'s Annual Report on Form 10-K for the fiscal
 year ending May 31, 1985).

10.18*	1986 Incentive Stock Option Plan, amended July 29, 1987, including
 form of Stock Option Agreement used thereunder (incorporated by reference
 to Exhibit 10.9 to Registration Statement No. 33-16275 on Form S-1).

10.19*	Agreement dated April 7, 1998, between the Company and Steven C. Ramsey 
(incorporated by reference to Exhibit 10.19 to Immucor's Annual Report on
 Form 10-K for the fiscal year ended May 31, 1998). 

10.20*	Agreement date July 26, 1997, between the Company and Josef Wilms
 (incorporated by reference to Exhibit 10.20 to Immucor's Annual Report on
 Form 10-K for the fiscal year ended May 31, 1998). 

21	Subsidiaries of the Registrant (incorporated by reference to Exhibit 21
 to Immucor's Annual Report on Form 10-K for the fiscal year ended May 31,
 1998). 

23.1	Consent of Ernst & Young LLP (incorporated by reference to Exhibit 23.1
 to Immucor's Annual Report on Form 10-K for the fiscal year ended May 31,
 1998). 

27	Financial Data Schedule (incorporated by reference to Exhibit 27 to
 Immucor's Annual Report on Form 10-K for the fiscal year ended May 31, 1998). 

27.1  Restated Financial Data Schedule for the fiscal years ended May 31,
 1997 and 1996.

    *Denotes a management contract or compensatory plan or arrangement.